INTERNATIONAL PATENT: ALLYX THERAPEUTICS, INC. FILES APPLICATION FOR "METHODS OF USE OF (4R,5R)-5-(2-CHLOROPHENYL)-4-(5-(PHENYLETHYNYL)PYRIDIN-3-YL)OXAZOLIDIN-2-ONE"

GENEVA, Sept. 17 -- ALLYX THERAPEUTICS, INC. (555 Long Wharf DriveNew Haven, CT 06511) filed a patent application (PCT/US2025/018314) for "METHODS OF USE OF (4R,5R)-5-(2-CHLOROPHENYL)-4-(5-(PHENYLETHYNYL)PYRIDIN-3-YL)OXAZOLIDIN-2-ONE" on Mar 04, 2025. With publication no. WO/2025/188734, the details related to the patent application was published on Sep 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SIEGERT, Timothy, Ryan (555 Long Wharf DriveNew Haven, CT 06511)

Abstract: The present disclosure provides methods of treating Alzheimer's disease and other disorders using (4R,5R)-5-(2-c...